Rigel Pharmaceuticals | RIGL - 销售成本





销售成本 更改 日
Agenus USD 642K 399K 2025-09
Amgen USD 1.6B 187M 2026-03
Anika Therapeutics USD 11.44M 797K 2025-12
AstraZeneca USD -204M 3.48B 2026-03
BioMarin Pharmaceutical USD 199.48M 37.93M 2026-03
Bristol-Myers Squibb USD 3.86B 1.07B 2026-03
Celldex Therapeutics USD 54.2M 8.94M 2025-06
Daiichi Sankyo JPY 118.28B 37.7B 2025-12
Eli Lilly USD 3.58B 205M 2026-03
Halozyme Therapeutics USD 108.75M 6.6M 2026-03
Heron Therapeutics USD 11.12M 795K 2025-12
Intrexon USD 1.01M 344K 2024-06
Ionis Pharmaceuticals USD 3M 5M 2026-03
Karyopharm Therapeutics USD 1.48M 35.95M 2025-12
Ligand Pharmaceuticals USD 11.37M 8.38M 2026-03
MacroGenics USD 9.53M 585K 2026-03
Neurocrine Biosciences USD 13.8M 3.8M 2026-03
Pfizer USD 4.59B 1.7B 2026-03
Regeneron Pharmaceuticals USD 669.4M 84.8M 2026-03
Rigel Pharmaceuticals USD 8.03M 5.22M 2024-09
Sangamo BioSciences 2.42M 1.11M 2024-06
Ultragenyx Pharmaceutical USD 30M 1000K 2026-03
Veracyte USD 38.49M 794K 2026-03